• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型口服头孢菌素头孢布烯的微生物学特征

Microbiologic profile of ceftibuten, a new oral cephalosporin.

作者信息

Debbia E A, Pesce A, Chiesa M, Ricotta N, Schito G C

机构信息

Institute of Microbiology, University of Genoa, Italy.

出版信息

Drugs Exp Clin Res. 1992;18(4):129-39.

PMID:1451643
Abstract

The bactericidal activity of ceftibuten, alone and in combination with other drugs, has been assessed in vitro. The ability to induce a post-antibiotic effect (PAE), the rate of emergence of spontaneous resistant mutants, and the presence of Eagle's phenomenon were also investigated. Ceftibuten rapidly killed most Enterobacteriaceae, Haemophilus, Moraxella and Streptococcus species tested, including beta-lactamase-producing strains with over 90% cfu reduction after only 2 h. Using chequerboard and time-kill tests, ceftibuten was found to react synergistically with aminoglycosides, and to give an indifferent response with ofloxacin against a large number of Gram-negative aerobes and streptococci. Antagonism was never observed. Ceftibuten induced a PAE of approximately 1 h on S. pneumoniae. As expected, no PAE was observed with Gram-negative species. Spontaneous emergence of ceftibuten-resistant strains exposed to supra-MICs of the drug was rare (< or = 10(-8)) in all pathogens tested. No marked Eagle effect was detected when bacteria were treated with ceftibuten at concentrations exceeding 100-fold their MICs. This rules out the possibility that in vivo the high concentrations of ceftibuten reached in the urinary tract may hinder its excellent bactericidal activity.

摘要

已在体外评估了头孢布烯单独及与其他药物联合使用时的杀菌活性。还研究了其诱导抗生素后效应(PAE)的能力、自发耐药突变体的出现率以及Eagle现象的存在情况。头孢布烯能迅速杀死大多数受试的肠杆菌科细菌、嗜血杆菌属、莫拉克斯氏菌属和链球菌属细菌,包括产β-内酰胺酶的菌株,仅2小时后cfu减少就超过90%。通过棋盘法和时间杀菌试验发现,头孢布烯与氨基糖苷类药物有协同反应,而与氧氟沙星对大量革兰氏阴性需氧菌和链球菌的反应呈无关作用。从未观察到拮抗作用。头孢布烯对肺炎链球菌诱导的PAE约为1小时。正如预期的那样,革兰氏阴性菌未观察到PAE。在所有受试病原体中,暴露于高于最低抑菌浓度(MIC)的头孢布烯时,头孢布烯耐药菌株的自发出现很少见(≤10^(-8))。当用超过其MIC 100倍的浓度的头孢布烯处理细菌时,未检测到明显的Eagle效应。这排除了在体内尿路中达到的高浓度头孢布烯可能阻碍其优异杀菌活性的可能性。

相似文献

1
Microbiologic profile of ceftibuten, a new oral cephalosporin.新型口服头孢菌素头孢布烯的微生物学特征
Drugs Exp Clin Res. 1992;18(4):129-39.
2
Antibacterial activity of ceftibuten, a new oral third generation cephalosporin.
J Chemother. 1991 Aug;3(4):209-25. doi: 10.1080/1120009x.1991.11739094.
3
Ceftibuten: a review of antimicrobial activity, spectrum and other microbiologic features.头孢布烯:抗菌活性、抗菌谱及其他微生物学特性综述
Pediatr Infect Dis J. 1995 Jul;14(7 Suppl):S77-83.
4
[A comparative study of antibacterial activity of ceftibuten, ceftazidime, cefuroxime and ampicillin against clinical isolates].头孢布烯、头孢他啶、头孢呋辛和氨苄西林对临床分离株抗菌活性的比较研究
Vutr Boles. 2000;32(1):13-7.
5
Antimicrobial activity and spectrum of ceftibuten (7432-S, SCH 39720)--a review of United States and Canadian results.
Diagn Microbiol Infect Dis. 1991 Jan-Feb;14(1):37-43. doi: 10.1016/0732-8893(91)90088-w.
6
Ceftibuten: minimal inhibitory concentrations, postantibiotic effect and beta-lactamase stability--a rationale for dosing programs.
Pediatr Infect Dis J. 1995 Jul;14(7 Suppl):S88-92.
7
In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes.头孢洛林(PPI-0903M,T-91825)对具有明确耐药机制和表型的细菌的体外活性。
J Antimicrob Chemother. 2007 Aug;60(2):300-11. doi: 10.1093/jac/dkm150. Epub 2007 Jun 4.
8
In-vitro activity of FCE 22101 against respiratory tract pathogens with reference to production of beta-lactamases.
J Antimicrob Chemother. 1989 Mar;23 Suppl C:31-41. doi: 10.1093/jac/23.suppl_c.31.
9
Antimicrobial effects of the combination of ceftibuten and an orally absorbed penem SCH 29482.头孢布烯与口服吸收性青霉烯类SCH 29482联合使用的抗菌作用
Diagn Microbiol Infect Dis. 1991 Jan-Feb;14(1):79-83. doi: 10.1016/0732-8893(91)90093-u.
10
[Comparative antibacterial activity of ceftibuten (SH 39 720) against 150 K. pneumoniae strains producing different beta-lactamases].
Pathol Biol (Paris). 1990 May;38(5):347-51.

引用本文的文献

1
Ceftibuten in ent infections.头孢布烯在耳鼻喉感染中的应用。
Indian J Otolaryngol Head Neck Surg. 1999 Apr;51(2):104-7. doi: 10.1007/BF02998005.
2
Comparison of ceftibuten vs. amoxicillin/clavulanic acid as antibiotic prophylaxis in cholecystectomy and/or biliary tract surgery.头孢布烯与阿莫西林/克拉维酸在胆囊切除术和/或胆道手术中作为抗生素预防性用药的比较。
J Gastrointest Surg. 2000 Nov-Dec;4(6):606-10. doi: 10.1016/s1091-255x(00)80109-2.
3
Ceftibuten. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy.
Drugs. 1994 May;47(5):784-808. doi: 10.2165/00003495-199447050-00006.